Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats.
about
A Liver-Centric Multiscale Modeling Framework for XenobioticsInvestigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver-kidney microfluidic data and pharmacokinetic-system biology models.Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbanceHuman biology-based drug safety evaluation: scientific rationale, current status and future challenges.Investigation of acetaminophen toxicity in HepG2/C3a microscale cultures using a system biology model of glutathione depletion.A novel approach for estimating ingested dose associated with paracetamol overdose.Modeling Pharmacokinetics.Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.Metabolic changes in the urine of andrographolide sodium bisulfite-treated rats.Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.Computational Modeling in Liver Surgery.First pass intestinal and liver metabolism of paracetamol in a microfluidic platform coupled with a mathematical modeling as a means of evaluating ADME processes in humans.An introduction to systems toxicology
P2860
Q27323311-1C228CDC-2930-40D2-BDB3-EB3BC7CFD30FQ30979147-9E4CE602-0957-477A-9C7A-6402842BD46DQ34571360-A1F271C9-9221-47BB-96EB-CCFBF04C43BFQ35181088-69709A7C-074D-41BA-B601-2919ADE2BE6BQ38763000-587D2CEC-011E-48BB-8F14-0379A39E35C1Q38877430-255B44B1-8B33-42E6-A190-2A85FCAE326CQ39220833-2F958FAE-0B1F-4485-A29F-B158B7A20D77Q39677925-99F6D319-5A3E-4E7F-A79A-8BB360BDC43DQ39923957-58E0017E-BD9A-4AC7-B1FF-CC6A5F7194B4Q41102775-203F08B6-32EE-49D4-A72A-005AF8BD9B53Q41504616-3B54A39D-D505-41C5-B226-D96505702270Q47145823-F4A17090-C144-42B6-B4D6-7842B68B8216Q51072946-F78C4470-DD4B-4122-82F4-8036E6888886Q58417419-AAED3761-B302-46B8-9BAC-616CAA9BF921
P2860
Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Multiscale modelling approach ...... oxoproline in humans and rats.
@en
Multiscale modelling approach ...... oxoproline in humans and rats.
@nl
type
label
Multiscale modelling approach ...... oxoproline in humans and rats.
@en
Multiscale modelling approach ...... oxoproline in humans and rats.
@nl
prefLabel
Multiscale modelling approach ...... oxoproline in humans and rats.
@en
Multiscale modelling approach ...... oxoproline in humans and rats.
@nl
P2093
P2860
P50
P356
P1433
P1476
Multiscale modelling approach ...... oxoproline in humans and rats.
@en
P2093
Ian D Wilson
James W T Yates
Suzanne Geenen
P2860
P304
P356
10.1039/C3IB20245C
P577
2013-06-01T00:00:00Z